PIM (proviral integration site for Moloney murine leukaemia virus) kinases, comprising three highly homologous serine/threonine kinases, are involved in the pathogenesis and progression of multiple malignancies, including AML and are important effectors of FLT3‐ITD activity. This evidence concerns the gene FLT3 and acute myeloid leukemia.